Josserand V - Search Results

1

Evaluation of drug penetration into the brain: a double study by in vivo imaging with positron emission tomography and using an in vitro model of the human blood-brain barrier.

Josserand V, Pélerin H, de Bruin B, Jego B, Kuhnast B, Hinnen F, Ducongé F, Boisgard R, Beuvon F, Chassoux F, Daumas-Duport C, Ezan E, Dollé F, Mabondzo A, Tavitian B. Josserand V, et al. J Pharmacol Exp Ther. 2006 Jan;316(1):79-86. doi: 10.1124/jpet.105.089102. Epub 2005 Oct 6. J Pharmacol Exp Ther. 2006. PMID: 16210395

2

In vivo mice lung tumor follow-up with fluorescence diffuse optical tomography.

Koenig A, Hervé L, Josserand V, Berger M, Boutet J, Da Silva A, Dinten JM, Peltié P, Coll JL, Rizo P. Koenig A, et al. Among authors: josserand v. J Biomed Opt. 2008 Jan-Feb;13(1):011008. doi: 10.1117/1.2884505. J Biomed Opt. 2008. PMID: 18315357 Free article.

3

Cyanine-loaded lipid nanoparticles for improved in vivo fluorescence imaging.

Texier I, Goutayer M, Da Silva A, Guyon L, Djaker N, Josserand V, Neumann E, Bibette J, Vinet F. Texier I, et al. Among authors: josserand v. J Biomed Opt. 2009 Sep-Oct;14(5):054005. doi: 10.1117/1.3213606. J Biomed Opt. 2009. PMID: 19895107 Free article.

4

Verteporfin-Loaded Lipid Nanoparticles Improve Ovarian Cancer Photodynamic Therapy In Vitro and In Vivo.

Michy T, Massias T, Bernard C, Vanwonterghem L, Henry M, Guidetti M, Royal G, Coll JL, Texier I, Josserand V, Hurbin AA. Michy T, et al. Among authors: josserand v. Cancers (Basel). 2019 Nov 8;11(11):1760. doi: 10.3390/cancers11111760. Cancers (Basel). 2019. PMID: 31717427 Free PMC article.

5

Targeted retroviral vectors displaying a cleavage site-engineered hemagglutinin (HA) through HA-protease interactions.

Szécsi J, Drury R, Josserand V, Grange MP, Boson B, Hartl I, Schneider R, Buchholz CJ, Coll JL, Russell SJ, Cosset FL, Verhoeyen E. Szécsi J, et al. Among authors: josserand v. Mol Ther. 2006 Nov;14(5):735-44. doi: 10.1016/j.ymthe.2006.04.007. Epub 2006 Jun 19. Mol Ther. 2006. PMID: 16784893 Free article.

6

Activatable fluorescent probes for tumour-targeting imaging in live mice.

Razkin J, Josserand V, Boturyn D, Jin ZH, Dumy P, Favrot M, Coll JL, Texier I. Razkin J, et al. Among authors: josserand v. ChemMedChem. 2006 Oct;1(10):1069-72. doi: 10.1002/cmdc.200600118. ChemMedChem. 2006. PMID: 16944544 No abstract available.

7

Noninvasive optical imaging of ovarian metastases using Cy5-labeled RAFT-c(-RGDfK-)4.

Jin ZH, Josserand V, Razkin J, Garanger E, Boturyn D, Favrot MC, Dumy P, Coll JL. Jin ZH, et al. Among authors: josserand v. Mol Imaging. 2006 Jul;5(3):188-97. Mol Imaging. 2006. PMID: 16954034

8

In vivo noninvasive optical imaging of receptor-mediated RGD internalization using self-quenched Cy5-labeled RAFT-c(-RGDfK-)(4).

Jin ZH, Razkin J, Josserand V, Boturyn D, Grichine A, Texier I, Favrot MC, Dumy P, Coll JL. Jin ZH, et al. Among authors: josserand v. Mol Imaging. 2007 Jan-Feb;6(1):43-55. Mol Imaging. 2007. PMID: 17311764

9

Hybrid gadolinium oxide nanoparticles: multimodal contrast agents for in vivo imaging.

Bridot JL, Faure AC, Laurent S, Rivière C, Billotey C, Hiba B, Janier M, Josserand V, Coll JL, Elst LV, Muller R, Roux S, Perriat P, Tillement O. Bridot JL, et al. Among authors: josserand v. J Am Chem Soc. 2007 Apr 25;129(16):5076-84. doi: 10.1021/ja068356j. Epub 2007 Mar 31. J Am Chem Soc. 2007. PMID: 17397154

10

In vivo optical imaging of integrin alphaV-beta3 in mice using multivalent or monovalent cRGD targeting vectors.

Jin ZH, Josserand V, Foillard S, Boturyn D, Dumy P, Favrot MC, Coll JL. Jin ZH, et al. Among authors: josserand v. Mol Cancer. 2007 Jun 12;6:41. doi: 10.1186/1476-4598-6-41. Mol Cancer. 2007. PMID: 17565663 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

85 results

Search Page